- Home
- HSTM vs EVMN Comparison
HSTM vs EVMN Comparison
Compare HSTM & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HSTM | EVMN |
|---|---|---|
| Founded | 1990 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.6M | 529.6M |
| IPO Year | 2000 | 2025 |
Fundamental Metrics
Financial Performance| Metric | HSTM | EVMN |
|---|---|---|
| Price | $21.70 | $19.38 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $28.00 | ★ $39.17 |
| AVG Volume (30 Days) | 248.6K | ★ 309.3K |
| Earning Date | 02-23-2026 | 06-10-2026 |
| Dividend Yield | ★ 0.57% | N/A |
| EPS Growth | ★ 4.75 | N/A |
| EPS | ★ 0.68 | N/A |
| Revenue | ★ $298,590,000.00 | $13,000,000.00 |
| Revenue This Year | $5.13 | $89.43 |
| Revenue Next Year | $4.89 | N/A |
| P/E Ratio | $32.08 | ★ N/A |
| Revenue Growth | 3.68 | ★ 160.00 |
| 52 Week Low | $21.00 | $13.89 |
| 52 Week High | $34.24 | $24.03 |
Technical Indicators
Market Signals| Indicator | HSTM | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 39.00 | 53.92 |
| Support Level | $21.00 | $16.36 |
| Resistance Level | $21.84 | $20.23 |
| Average True Range (ATR) | 0.59 | 1.82 |
| MACD | 0.03 | 0.09 |
| Stochastic Oscillator | 31.04 | 63.56 |
Price Performance
Historical ComparisonAbout HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
About EVMN Evommune Inc.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.